Novel protein kinases in pancreatic cell growth and cancer.

Int J Gastrointest Cancer

Department of Internal Medicine, Medical University of Ulm/Germany, Abt. Innere Medizin I, Medizinische Universitaetsklinik Ulm, Robert-Koch Str 8, D-89081 Ulm, Germany.

Published: September 2003

The network of enzymes that contribute to the signal transduction of extracellular factors in pancreatic cancer is ever increasing. The classical Raf-MEK-ERK signaling cascade plays a crucial role in the regulation of apoptosis, proliferation, and metastasis of pancreatic cancer. Phosphatidylinositide-3-kinase also contributes to growth and prevents apoptosis in pancreatic cancer cells, acting in part via its downstream targets, PKB/AKT and the FRAP/p70s6k signaling complex. Recently, members of the PKC family of serine threonine kinases have emerged as novel modulators of transformation and cell cycle progression of pancreatic cancers. The novel PKD family of serine threonine kinases has just been detected in pancreatic cancer and awaits its functional characterization in these tumors.

Download full-text PDF

Source
http://dx.doi.org/10.1385/IJGC:31:1-3:15DOI Listing

Publication Analysis

Top Keywords

pancreatic cancer
16
family serine
8
serine threonine
8
threonine kinases
8
pancreatic
6
cancer
5
novel protein
4
protein kinases
4
kinases pancreatic
4
pancreatic cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!